Sindrome di Birt-Hogg-Dubé
Revisione paritaria di Dr Surangi Mendis, MRCGPUltimo aggiornamento di Dr Doug McKechnie, MRCGPUltimo aggiornamento 20 Set 2023
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Versione audio
- Add to preferred sources on Google
Professionisti Medici
Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our articoli sulla salute more useful.
In questo articolo:
Synonym: fibrofolliculomas with trichodiscomas and acrochordons
Continua a leggere sotto
Che cos'è Birt-Hogg-Dubé syndrome?
Birt-Hogg-Dubé syndrome is named after the three authors of a paper that described family members with papular skin lesions on their face, forehead, scalp and neck.1
When these lesions were examined, the following were found:2
Fibrofolliculomas (benign tumours of the hair follicle).
Trichodiscomas (hamartomatous tumours of the hair disc).
Acrocordoni ('wart with a thin neck' skin tags).
This triad of features became known as Birt-Hogg-Dubé syndrome. Later reports identified the presence of multiple lung cysts in patients with Birt-Hogg-Dubé syndrome (leading to spontaneous pneumothoraces), as well as an elevated risk of renal cancers.3
It has also been suggested that trichodischomas and fibrofolliculomas are the same lesions, but sectioned in different planes, leading to differing histological interpretations.4
Genetica
Torna ai contenutiBirt-Hogg-Dubé syndrome is a rare inherited genodermatosis.2
The condition is caused by a mutation in the folliculin (FLCN) gene, a tumour suppressor gene.3
The mutation is at gene map locus 17p11.2.
An autosomal dominant inheritance pattern has been identified.5
Continua a leggere sotto
How common is Birt-Hogg-Dubé syndrome? (Epidemiologia)
Torna ai contenutiThe actual prevalence is unknown, but it is likely to be underdiagnosed.6 One meta-analysis, using a Bayesian approach, estimated a prevalence of 2 per million people.7
About 600 affected families have been described to date in the medical literature.8
Symptoms of Birt-Hogg-Dubé syndrome (presentazione)
Torna ai contenutiOnset tends to be in adulthood with skin lesions:2
These develop in the 20s or 30s and remain throughout life.
They are typically small, dome-shaped, papular skin lesions, about 2 mm to 4 mm in diameter, that develop over the scalp, face, neck and upper trunk. They may also be seen in the mouth.
They cause no symptoms and the reason for presentation is usually cosmetic.
Acrochordons are warty-like acrocordi that may be found on the eyelids, neck, axilla and upper half of the trunk. Skin tags are very common in the general population, and therefore not diagnostic for Birt-Hogg-Dubé syndrome.
Presentation may also be with renal carcinoma, spontaneous pneumothorax or other possible associated conditions - see below.
Continua a leggere sotto
Associazioni
Torna ai contenutiThere are a number of conditions associated with Birt-Hogg-Dubé syndrome, including:3
Renal carcinomas (may be multifocal and/or bilateral; most commonly chromophobe renal carcinoma and oncocytic hybrid tumours).9
Pulmonary cysts: these occur frequently, affecting about 70-84% of people with the syndrome.3
Spontaneous pneumothorax.
These are thought to result from a mutation in the FLCN gene. The conditions below are other possible associations.10
Connective tissue naevi.
Parathyroid adenomas.
Flecked chorioretinopathy.
Lipomi and angiolipomas.
Parotid oncocytomas.
Multiple oral mucosal papules.
Neural tissue tumours.
Multiple facial angiofibromas.
Polipi del colon and colonic adenocarcinoma.
Multinodular goiters.
Medullary thyroid carcinoma.
Diagnosing Birt-Hogg-Dubé syndrome (investigations)
Torna ai contenutiInformazioni importanti |
|---|
Birt-Hogg-Dubé syndrome should be looked for in any patient with multiple bilateral kidney tumours, especially if the predominant histological type is chromophobe carcinoma a cellule renali or hybrid oncocytic tumour.11 |
Skin biopsy will confirm the nature of the lesions.
Molecular genetic testing is available, and demonstrating a germline FLCN mutation gives definitive diagnostic confirmation.3
CXR or CT chest (may show pulmonary cysts, bullous emphysema or pneumothorax).
Renal ultrasound and CT scan of the abdomen/pelvis should be performed to screen for renal tumours. Relatives should also be screened for renal cancer.
Consider colonoscopy because of the possible association with colonic polyps/carcinoma, although this is debated.12 13
Management of Birt-Hogg-Dubé syndrome
Torna ai contenutiThere is no specific therapy.
Skin lesions may be treated by surgical removal. Dermabrasion, electrodesiccation and laser treatment have been used but the lesions may recur.
There should be long-term follow-up for malignant change, especially renal carcinoma. Abdominal CT or MRI is generally recommended for surveillance in these patients, as ultrasound may not detect small or isoechoic hybrid oncocytic and chromophobe tumours.3
Enhanced screening for colorectal cancer may also be useful, although this is disputed, as the link between Birt-Hogg-Dubé syndrome and colorectal malignancy is not clear.
Monitoring and screening for associated chest conditions should be carried out.
Smoking is a strong risk factor for both spontaneous pneumothorax and renal cancer. There are limited data on how smoking interacts with the existing risks in Birt-Hogg-Dubé syndrome, but it seems prudent to recommend smoking cessation and avoidance in these patients.
Associated conditions should be managed appropriately.
Consulenza genetica should be offered.
Prognosi
Torna ai contenutiThis depends on the development of associated conditions, especially renal carcinoma.
The tendency for associated malignancy seems variable between families.
Specific mutations in the folliculin gene may predispose to cancer development in Birt-Hogg-Dubé syndrome.14
Malignancy is not an invariable part of the disease.
Prevention of Birt-Hogg-Dubé syndrome
Torna ai contenutiThere are no specific preventative measures for Birt-Hogg-Dubé syndrome, other than smoking cessation and enhanced surveillance (as above) to detect complications early.
Genetic counselling may help people with Birt-Hogg-Dubé syndrome understand their options for family planning. Prenatal diagnosis (for at-risk pregnancies) and preimplantation genetic testing are possible if the FLCN pathogenic variant has been identified in a family member.15
Ulteriori letture e riferimenti
- Sindrome di Birt-Hogg-Dubé; DermNet NZ
- Kluger N, Giraud S, Coupier I, et al; Birt-Hogg-Dube syndrome: clinical and genetic studies of 10 French families. Br J Dermatol. 2010 Mar;162(3):527-37. Epub 2009 Sep 26.
- BHD Foundation
- Birt AR, Hogg GR, Dubé WJ; Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol. 1977 Dec;113(12):1674-7.
- Birt-Hogg-Dube Syndrome, Online Mendelian Inheritance in Man (OMIM)
- Schmidt LS, Linehan WM; Molecular genetics and clinical features of Birt-Hogg-Dube syndrome. Nat Rev Urol. 2015 Oct;12(10):558-69. doi: 10.1038/nrurol.2015.206. Epub 2015 Sep 1.
- Schulz T, Hartschuh W; Birt-Hogg-Dube syndrome and Hornstein-Knickenberg syndrome are the same. Different sectioning technique as the cause of different histology. J Cutan Pathol. 1999 Jan;26(1):55-61. doi: 10.1111/j.1600-0560.1999.tb01792.x.
- Toro JR, Wei MH, Glenn GM, et al; BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube J Med Genet. 2008 Jun;45(6):321-31. Epub 2008 Jan 30.
- Kim EH, Jeong SY, Kim HJ, et al; A case of Birt-Hogg-Dubé syndrome. J Korean Med Sci. 2008 Apr;23(2):332-5.
- Muller ME, Daccord C, Taffe P, et al; Prevalence of Birt-Hogg-Dube Syndrome Determined Through Epidemiological Data on Spontaneous Pneumothorax and Bayes Theorem. Front Med (Lausanne). 2021 Apr 27;8:631168. doi: 10.3389/fmed.2021.631168. eCollection 2021.
- Birt-Hogg-Dubé Syndrome; Rare Disease Database, July 2023.
- Schmidt LS; Birt-Hogg-Dubé syndrome, a genodermatosis that increases risk for renal carcinoma. Curr Mol Med. 2004 Dec;4(8):877-85.
- Menko FH, van Steensel MA, Giraud S, et al; Birt-Hogg-Dube syndrome: diagnosis and management. Lancet Oncol. 2009 Dec;10(12):1199-206. doi: 10.1016/S1470-2045(09)70188-3.
- Adley BP, Smith ND, Nayar R, et al; Birt-Hogg-Dubé syndrome: clinicopathologic findings and genetic alterations. Arch Pathol Lab Med. 2006 Dec;130(12):1865-70.
- Zbar B, Alvord WG, Glenn G, et al; Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):393-400.
- Le Guyadec T, Dufau JP, Poulain JF, et al; Multiple trichodiscomas associated with colonic polyposis. Ann Dermatol Venereol. 1998 Oct;125(10):717-9.
- Palmirotta R, Donati P, Savonarola A, et al; Birt-Hogg-Dubé (BHD) syndrome: report of two novel germline mutations in the folliculin (FLCN) gene. Eur J Dermatol. 2008 Jul-Aug;18(4):382-6. Epub 2008 Jun 23.
- Sattler EC, Steinlein OK; Birt-Hogg-Dubé Syndrome, GeneReviews, January 2020.
Continua a leggere sotto
About the author

Dr Doug McKechnie, MRCGP
Medical Writer
MA, MBBS, MSc, DRCOG, MRCP(UK), MRCGP(2021), FHEA
Dr Doug McKechnie is an NHS GP working in London. He works full-time clinically and is also the Deputy Lead for the Clinical and Professional Practice module at University College London Medical School.
About the reviewerView full bio

Dr Surangi Mendis, MRCGP
Consultant and Medical Author
MBBS, BSc (1st), MRCGP (2014), DFSRH, PGcert otology and audiology
Surangi Mendis is a consultant in Audiovestibular Medicine and Neuro-otology at The Royal National ENT and Eastman Dental Hospitals, UCLH.
Storia dell'articolo
Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.
Prossima revisione prevista: 18 Set 2028
20 Set 2023 | Ultima versione

Chiedi, condividi, connettiti.
Esplora le discussioni, fai domande e condividi esperienze su centinaia di argomenti di salute.

Non ti senti bene?
Valuta i tuoi sintomi online gratuitamente